Works matching Cytogenetics

Results: 5000
    1
    2
    3
    4
    5
    6

    High expression of activation-induced cytidine deaminase (AID) mRNA is associated with unmutated IGV<sub>H</sub> gene status and unfavourable cytogenetic aberrations in patients with chronic lymphocytic leukaemia.

    Published in:
    Leukemia (08876924), 2004, v. 18, n. 4, p. 756, doi. 10.1038/sj.leu.2403294
    By:
    • Heintel, D.;
    • Kroemer, E.;
    • Kienle, D.;
    • Schwarzinger, I.;
    • Gleiß, A.;
    • Schwarzmeier, J.;
    • Marcuiescu, R.;
    • Le, T.;
    • Mannhalter, C.;
    • Gaiger, A.;
    • Stilgenbauer, S.;
    • Döhner, H.;
    • Fonatsch, C.;
    • Jäger, U.
    Publication type:
    Article
    7

    Circulating plasma cells in newly diagnosed symptomatic multiple myeloma as a possible prognostic marker for patients with standard-risk cytogenetics.

    Published in:
    British Journal of Haematology, 2015, v. 170, n. 4, p. 523, doi. 10.1111/bjh.13484
    By:
    • Vagnoni, Davide;
    • Travaglini, Fosco;
    • Pezzoni, Valerio;
    • Ruggieri, Miriana;
    • Bigazzi, Catia;
    • Dalsass, Alessia;
    • Mestichelli, Francesca;
    • Troiani, Emanuela;
    • Falcioni, Sadia;
    • Mazzotta, Serena;
    • Natale, Annalisa;
    • Angelini, Mario;
    • Ferretti, Silvia;
    • Angelini, Stefano;
    • Galieni, Piero
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Failure matters: unsuccessful cytogenetics and unperformed cytogenetics are associated with a poor prognosis in a population-based series of acute myeloid leukaemia.

    Published in:
    European Journal of Haematology, 2015, v. 94, n. 5, p. 419, doi. 10.1111/ejh.12446
    By:
    • Lazarevic, Vladimir;
    • Hörstedt, Ann‐Sofi;
    • Johansson, Bertil;
    • Antunovic, Petar;
    • Billström, Rolf;
    • Derolf, Åsa;
    • Lehmann, Sören;
    • Möllgård, Lars;
    • Peterson, Stefan;
    • Stockelberg, Dick;
    • Uggla, Bertil;
    • Vennström, Lovisa;
    • Wahlin, Anders;
    • Höglund, Martin;
    • Juliusson, Gunnar
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41

    Treatment of patients with relapsed/refractory multiple myeloma with lenalidomide and dexamethasone with or without bortezomib: prospective evaluation of the impact of cytogenetic abnormalities and of previous therapies.

    Published in:
    Leukemia (08876924), 2010, v. 24, n. 10, p. 1769, doi. 10.1038/leu.2010.175
    By:
    • Dimopoulos, M. A.;
    • Kastritis, E.;
    • Christoulas, D.;
    • Migkou, M.;
    • Gavriatopoulou, M.;
    • Gkotzamanidou, M.;
    • Iakovaki, M.;
    • Matsouka, C.;
    • Mparmparoussi, D.;
    • Roussou, M.;
    • Efstathiou, E.;
    • Terpos, E.
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49
    50